I-Ensitrelvir (S-217622) ePhakathi CAS 1360105-53-8 Ubunyulu >98.0% i-COVID-19 Umfanekiso ofakiweyo

I-Ensitrelvir (S-217622) ePhakathi CAS 1360105-53-8 Ubunyulu >98.0% COVID-19

Inkcazelo emfutshane:

Igama leMichiza: 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-

CAS: 1360105-53-8

Ubunyulu: >98.0% (HPLC)

Umbindi we-Ensitrelvir (S-217622), COVID-19

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo ngezoRhwebo lwe-Ensitrelvir (S-217622) abaPhakathi:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
I-Trimethyloxonium Tetrafluoroborate CAS 420-37-1
I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4 (1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Iipropati zeMichiza:

Igama leMchiza	1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-
Izithethantonye	3-tert-butyl-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione
Inombolo yeCAS	1360105-53-8
Inombolo yeCAT	RF-PI1504
Ubume beStokhwe	Ikhona evenkileni
Ifomula yeemolekyuli	I-C9H15N3O2S
Ubunzima beMolekyuli	229.3
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Ubunyulu	>98.0%
Ilahleko ekomisweni	<1.00%
Ukungcola ngokupheleleyo	<2.00%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi we-Ensitrelvir (S-217622), COVID-19

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-3-(Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride (CAS: 135206-76-7) iphakathi kwe-Ensitrelvir (S-217622).I-Ensitrelvir lichiza le-antiviral eliphuhliswe yi-Shionogi ngentsebenziswano neYunivesithi yaseHokkaido, esebenza njenge-3C-like protease inhibitor esebenza ngomlomo kunyango losulelo lwe-COVID-19.Ithathwa ngomlomo, kwaye iye yavavanywa ngempumelelo ngokuchasene nokwahluka kwe-Omicron esanda kuvela.Yaba yipilisi yasekhaya yokuqala yaseJapan ukunyanga i-COVID-19, eyesithathu ukuba yamkelwe ngokusemthethweni eJapan;ngoFebruwari 2022.